News & Updates

In neonates with congenital diaphragmatic hernia, early treatment with prostacyclin appears to reduce the need for extracorporeal life support in the postnatal period, according to a study.

Use of antiosteoporotic medication, particularly a long-acting regimen, appears to reduce postfracture mortality, according to a population-based study.

Treatment with the investigational, topical pan-JAK inhibitor delgocitinib cream led to significantly greater improvements in efficacy outcomes compared with the vehicle cream in moderate-to-severe chronic hand eczema (CHE) in the pivotal phase III DELTA 1 trial, offering a rational strategy for targeted therapy.

For adults undergoing surgery, melatonin appears to help reduce the likelihood of postoperative delirium, according to the results of a meta-analysis.

Growth hormone (GH), compared with catecholamines, appears to be a better facilitator for the change from glucose to fatty acid metabolism following SGLT2 inhibitor use during exercise, reveals a study.

A phase II nonrandomized trial of trabectedin in combination with radiotherapy for the treatment of myxoid liposarcoma has failed to meet its endpoint, although this treatment combination appears to be well tolerated in patients.

Sarecycline demonstrated efficacy for the treatment of moderate-to-severe facial acne vulgaris in patients with skin of colour, according to a post hoc analysis of two phase III trials presented at AAD 2023.